Ratna Karuna

1.2k total citations
9 papers, 378 citations indexed

About

Ratna Karuna is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Ratna Karuna has authored 9 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 3 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Ratna Karuna's work include Cholesterol and Lipid Metabolism (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Mosquito-borne diseases and control (3 papers). Ratna Karuna is often cited by papers focused on Cholesterol and Lipid Metabolism (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Mosquito-borne diseases and control (3 papers). Ratna Karuna collaborates with scholars based in Switzerland, Singapore and Netherlands. Ratna Karuna's co-authors include Arnold von Eckardstein, Katharina Rentsch, Mohammad Mahdi Motazacker, Adriaan G. Holleboom, Jan Albert Kuivenhoven, Gang Wang, Siew Pheng Lim, Pei‐Yong Shi, Fumiaki Yokokawa and Lucia Rohrer and has published in prestigious journals such as Journal of Virology, Journal of Medicinal Chemistry and Atherosclerosis.

In The Last Decade

Ratna Karuna

9 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ratna Karuna Switzerland 9 144 128 107 93 42 9 378
Kathleen M. Heinz-Taheny United States 9 121 0.8× 80 0.6× 30 0.3× 88 0.9× 21 0.5× 18 354
Helen Gu United States 12 112 0.8× 54 0.4× 49 0.5× 75 0.8× 103 2.5× 19 507
Laura N. Cruz Brazil 9 141 1.0× 98 0.8× 29 0.3× 33 0.4× 8 0.2× 15 331
Albert Théophane Yonli Burkina Faso 12 105 0.7× 18 0.1× 50 0.5× 56 0.6× 20 0.5× 68 503
Sandra De Jonghe Belgium 11 131 0.9× 12 0.1× 54 0.5× 39 0.4× 64 1.5× 27 401
Hye In Woo South Korea 12 58 0.4× 101 0.8× 56 0.5× 66 0.7× 32 0.8× 24 346
L. Bachmetov Israel 5 57 0.4× 20 0.2× 44 0.4× 49 0.5× 19 0.5× 5 367
Riyasat Ali India 13 139 1.0× 17 0.1× 55 0.5× 70 0.8× 49 1.2× 26 500
Suwagmani Hazarika United States 10 97 0.7× 27 0.2× 16 0.1× 25 0.3× 27 0.6× 10 425

Countries citing papers authored by Ratna Karuna

Since Specialization
Citations

This map shows the geographic impact of Ratna Karuna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ratna Karuna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ratna Karuna more than expected).

Fields of papers citing papers by Ratna Karuna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ratna Karuna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ratna Karuna. The network helps show where Ratna Karuna may publish in the future.

Co-authorship network of co-authors of Ratna Karuna

This figure shows the co-authorship network connecting the top 25 collaborators of Ratna Karuna. A scholar is included among the top collaborators of Ratna Karuna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ratna Karuna. Ratna Karuna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Liu, Bo, Yi Yang See, Gang Wang, et al.. (2021). A head-to-head comparison of the inhibitory activities of 15 peptidomimetic SARS-CoV-2 3CLpro inhibitors. Bioorganic & Medicinal Chemistry Letters. 48. 128263–128263. 18 indexed citations
2.
Kounde, Cyrille S., Qingyin Wang, Kah Fei Wan, et al.. (2017). Discovery of 2-oxopiperazine dengue inhibitors by scaffold morphing of a phenotypic high-throughput screening hit. Bioorganic & Medicinal Chemistry Letters. 27(6). 1385–1389. 15 indexed citations
3.
Yokokawa, Fumiaki, Shahul Nilar, Christian G. Noble, et al.. (2016). Discovery of Potent Non-Nucleoside Inhibitors of Dengue Viral RNA-Dependent RNA Polymerase from a Fragment Hit Using Structure-Based Drug Design. Journal of Medicinal Chemistry. 59(8). 3935–3952. 77 indexed citations
4.
Karuna, Ratna, Isabelle Christen, Andreas W. Sailer, Francis Bitsch, & Juan Zhang. (2015). Detection of dihydroxycholesterols in human plasma using HPLC–ESI-MS/MS. Steroids. 99(Pt B). 131–138. 21 indexed citations
5.
Chen, Yen‐Liang, Ratna Karuna, Siew Pheng Lim, et al.. (2013). Activation of Peripheral Blood Mononuclear Cells by Dengue Virus Infection Depotentiates Balapiravir. Journal of Virology. 88(3). 1740–1747. 64 indexed citations
6.
Karuna, Ratna, Alaa Othman, Adriaan G. Holleboom, et al.. (2011). Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism. Atherosclerosis. 219(2). 855–863. 81 indexed citations
7.
Holleboom, Adriaan G., Ratna Karuna, Mohammad Mahdi Motazacker, et al.. (2011). Lipoprotein distribution and serum concentrations of 7α-hydroxy-4-cholesten-3-one and bile acids: effects of monogenic disturbances in high-density lipoprotein metabolism. Clinical Science. 122(8). 385–400. 12 indexed citations
8.
Karuna, Ratna, Adriaan G. Holleboom, Mohammad Mahdi Motazacker, et al.. (2010). Plasma levels of 27-hydroxycholesterol in humans and mice with monogenic disturbances of high density lipoprotein metabolism. Atherosclerosis. 214(2). 448–455. 54 indexed citations
9.
Karuna, Ratna, Arnold von Eckardstein, & Katharina Rentsch. (2008). Dopant assisted-atmospheric pressure photoionization (DA-APPI) liquid chromatography–mass spectrometry for the quantification of 27-hydroxycholesterol in plasma. Journal of Chromatography B. 877(3). 261–268. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026